This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Prescribing cannibinoid products
Sunday 1 July 2018, 12:00 PM
Regulating medicinal cannabis is difficult and complex
The prescribing and use of cannabis-based medicines is strictly regulated in New Zealand. University of Auckland pharmacy law lecturer Sanya Ram explores the current legal requirements for prescribing and dispensing cannabinoid products
The therapeutic potential for medicinal cannabis has been topical and has provoked much debate globally.
Regulating medicinal cannabis is difficul
References
- Zolotov Y, Vulfsons S, Zarhin D, et al. Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. Int J Drug Policy 2018;57(7):4–10.
- Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 2015;313(24):2456–73.
- Misuse of Drugs Act,1975 (NZ).
- Misuse of Drugs Regulations,1977 (NZ).
- Ministry of Health. CBD products. Available from: www.health.govt.nz (Accessed May, 2018).
- Ministry of Health. Prescribing cannabis based products. Available from: www.health. govt.nz (Accessed May, 2018).
- Misuse of Drugs Regulations,1977 (NZ), regulation 29 (1A).
- Medicines Act, 1981 (NZ), s29.
- Medsafe. Sativex oromucosal spray. Available from: www.medsafe.govt.nz (Accessed May 2018).